drug prices
Trump Administration Drops Plans to Impose Tariffs on Generic Drugs: A Positive Development for Indian Pharmaceutical Industry
Oct 10, 2025 06:25 pm CST
The Trump administration has decided against implementing tariffs on generic drugs imported from foreign countries, providing relief to both Indian pharmaceutical manufacturers, who supply nearly half of all generic prescriptions in the US market, and American consumers who depend on affordable medications. This decision comes after President Trump had previously announced 100 percent tariffs on branded drugs starting October 1.
Trump Jokes About COVID When Health Secretary Kennedy Sneezes During Pfizer Drug Price Announcement
Oct 01, 2025 03:39 pm CST
During a White House briefing on prescription drug costs, President Trump jokingly requested Paxlovid when Health Secretary Robert F Kennedy Jr sneezed behind him. The meeting also featured announcements about a Pfizer tariff exemption and the launch of "TrumpRx," a new government website designed to reduce medication costs for Americans by eliminating middlemen in the pharmaceutical supply chain.
Trump Announces Major Pfizer Deal to Lower US Drug Prices After Humorous COVID Moment in Oval Office
Oct 01, 2025 03:39 pm CST
President Trump unveiled a groundbreaking agreement with Pfizer aimed at reducing prescription drug costs in the US, during a White House briefing that featured a lighthearted moment when Health Secretary Robert F Kennedy Jr sneezed nearby. The deal includes a new "TrumpRx" platform allowing direct consumer purchases from Pfizer, bypassing middlemen, while also granting the company a three-year exemption from recently announced pharmaceutical tariffs.
Trump's 100% Pharmaceutical Tariffs: Global Impact on Countries and Companies
Sep 26, 2025 10:59 pm CST
President Trump's announcement of 100% tariffs on imported branded pharmaceuticals has sent shockwaves through the global drug industry. This policy, set to take effect in five days unless companies begin constructing US manufacturing facilities, threatens international pharmaceutical trade worth $252 billion annually. While the European Union claims protection through an existing trade agreement, countries like Switzerland and Denmark face significant risks. Pharmaceutical giants have already pledged $300 million in US investments as companies scramble to adapt to this protectionist measure that exempts generic medications but targets patented drugs.